Anthracene-d10 solution

Hazard statements (CLP)

H315, H319, H336, H351, H373, H411

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

Regulation (EC) No. 1272/2008 Classification of the substance or mixture

Signal word

Danger Danger

Hazard statements

H315 Causes skin irritation. H319 Causes serious eye irritation. H336 May cause drowsiness or dizziness. H351 Suspected of causing cancer. H373 May cause damage to organs (Liver, Blood) through prolonged or repeated exposure if swallowed. H373 May cause damage to organs (Central nervous system) through prolonged or repeated exposure if inhaled. H411 Toxic to aquatic life with long lasting effects. EUH440 Accumulates in the environment and living organisms including in humans. H351 Suspected of causing cancer. EUH440 Accumulates in the environment and living organisms including in humans.

Precautionary statements

P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P273 Avoid release to the environment. P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P273 Avoid release to the environment. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P391 Collect spillage. P501 Dispose of contents/ container to an approved waste disposal plant.

Response

P308 + P313 IF exposed or concerned: Get medical advice/ attention. P391 Collect spillage.

Disposal

P501 Dispose of contents/ container to an approved waste disposal plant.

Hazardous Ingredients

Dichloromethane Reduced Labelling (<= 125 ml)

Supplemental label elements

none

2.3 Other hazards

This substance/mixture contains components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB).

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

2.1 Classification of the substance or mixture

Classification (REGULATION (EC) No 1272/2008) Skin irritation, Category 2 H315: Causes skin irritation. Eye irritation, Category 2 H319: Causes serious eye irritation. Carcinogenicity, Category 2 H351: Suspected of causing cancer. Specific target organ toxicity - H336: May cause drowsiness or dizziness. single exposure, Category 3, Central nervous system Specific target organ toxicity - H373: May cause damage to organs through repeated exposure, Category 2, prolonged or repeated exposure if Liver, Blood swallowed. Specific target organ toxicity - H373: May cause damage to organs through repeated exposure, Category 2, prolonged or repeated exposure if inhaled. Central nervous system Long-term (chronic) aquatic hazard, H411: Toxic to aquatic life with long lasting Category 2 effects. Persistent, bioaccumulative and EUH440: Accumulates in the environment toxic and living organisms including in humans.